Plasma from some cancer patients inhibits adenoviral Ad5f35 vector transduction of dendritic cells

The manufacture of adHER2/neu DC using autologous plasma as a media supplement resulted in inconsistent HER2/neu expression. It is likely that variability in the levels of multiple proteins in autologous plasma contributed to low HER2/neu expression.